BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Cutting Edge Technology From Japan at Biotechnology Industry Organization (BIO) Convention in Chicago


4/10/2013 11:59:28 AM

CHICAGO, IL--(Marketwired - April 10, 2013) - The Japan External Trade Organization (JETRO) is organizing the Japan Pavilion at the 2013 BIO International Convention, to be held at Chicago's McCormick Place from Monday, April 22 to Thursday, April 25. Nineteen companies from Japan will be on display in the Japan Pavilion (Booth 3611), exhibiting some of the most innovative biotechnology from Japan.

Key technologies to be featured at the Japan Pavilion include new treatments for oncology, pain management, cognitive disorders and neurological disorders; advancements in regenerative medicine; drug discovery tools; and contract manufacturing and R&D.

Three of the companies in the Pavilion will be representing technologies developed at some of Japan's leading universities. iPS Academia Japan manages patents from Kyoto University, including the iPS pluripotent stem cells technology developed by Dr. Shinya Yamanaka, winner of the 2012 Nobel Prize for Medicine. Todai TLO, which represents technology developed by the University of Tokyo, will feature a novel treatment for cardiovascular disease. MPO Inc. will show their new regenerative medicine technique which utilizes cardiac stem cells.

The Japan Pavilion exhibitors will also participate in BIO's One-on-One Partnering meetings. The Japanese delegates are eager to meet new strategic development and distribution partners.

The annual BIO Convention, organized by the Biotechnology Industry Organization, is the largest event for the biotechnology sector, attracting over 16,000 attendees from all over the world. JETRO has organized the Japan Pavilion since 2003.

ABOUT JETRO
The Japan External Trade Organization (JETRO) is an incorporated administrative agency operating under the auspices of Japan's Ministry of Economy, Trade and Industry (METI) to promote mutual trade and investment between Japan and the rest of the world. Utilizing our network of more than 70 overseas offices and 36 in Japan, JETRO carries out a range of activities, including: facilitating foreign direct investment into Japan; helping Japan's small and medium-size firms maximize their export potential; and promoting Japanese products abroad.

In the field of biotechnology, JETRO provides market information and consulting to Japanese companies interested in entering foreign markets and to foreign companies interested in expanding into Japan. JETRO also coordinates periodic business matching opportunities at conferences and tradeshows around the world.

For more information, visit jetro.org or contact Robert Corder at JETRO Chicago.


Robert Corder
Project Coordinator
JETRO Chicago
TEL 312-833-6000 x204
FAX 312-832-6066
EMAIL Email Contact



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES